Posts by: Marta Figueiredo

Marta Figueiredo

Marta Figueiredo holds a BSc in Biology and a MSc in Evolutionary and Developmental Biology from the University of Lisbon, Portugal. She is currently finishing her PhD in Biomedical Sciences at the University of Lisbon, where she focused her research on the role of several signalling pathways in thymus and parathyroid glands embryonic development.

December 8, 2017December 8, 2017

Inhaled Thyroid Hormone May Work to Reverse Lung Fibrosis, Early Study Reports

Idiopathic Pulmonary Fibrosis, News

A study led by researchers at Yale School of Medicine showed that an inhalation treatment based on thyroid hormone can significantly reverse lung scarring (fibrosis) in mice models of pulmonary fibrosis and ... Read more

December 6, 2017December 12, 2017

Former Football Player Helping CF Patients Obtain AffloVest Airway-clearing Devices

Cystic Fibrosis, News

A former American football player’s foundation is teaming up with AffloVest to provide one of the company’s airway-clearing devices to a cystic fibrosis patient in each of the 50 states. The partners are ... Read more

December 1, 2017December 1, 2017

Restoring a DNA Repair Protein Reverses Lung Scarring, Mouse Study in Germany Shows

Idiopathic Pulmonary Fibrosis, News

Restoring a DNA repair protein that is missing in pulmonary fibrosis reversed the lung scarring that is the hallmark of the disease, a German study in mice has shown. The ... Read more

November 29, 2017November 29, 2017

Boston and Toronto Researchers Discover Two Additional Molecules Involved in Lung Scarring

Idiopathic Pulmonary Fibrosis, News

Researchers in Boston and Toronto have discovered another molecular mechanism involved in lung scarring. The team at Massachusetts General Hospital and Toronto’s University Health Network said scientists might be able to develop a ... Read more

November 27, 2017November 27, 2017

New York’s Montefiore Einstein Center Launches Lung Transplant Program

COPD, Cystic Fibrosis, Idiopathic Pulmonary Fibrosis, News

New York City’s Montefiore Einstein Center for Heart & Vascular Care has received interim approval from the United Network for Organ Sharing (UNOS) to launch its new lung transplant program. Lung transplant ... Read more

November 13, 2017November 13, 2017

Esbriet Safe but Less Effective in Severe IPF Patients After 6 Months of Treatment, Small Study Says

Idiopathic Pulmonary Fibrosis, News

A retrospective real-world study found that the benefits of Esbriet (pirfenidone) in people with advanced idiopathic pulmonary fibrosis (IPF) appeared to diminish after six months of treatment, although side effects were ... Read more

November 8, 2017November 8, 2017

FDA Approves Genentech’s Alecensa as First-line Therapy for ALK-positive, Advanced NSCLC

Lung Cancer, News

The U.S. Food and Drug Administration (FDA) has approved Alecensa (alectinib), by Genentech, as a front-line treatment for people with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC). Results from ... Read more